Reaction Details Report a problem with these data
Target
Vitamin D3 receptor
Ligand
BDBM50207144
Substrate
n/a
Meas. Tech.
Dopamine D3 Receptor Binding Test
Ki
0.180±n/a nM
Citation
 Li, J; Chen, X; Ma, Z; Zhang, L; Cui, N Benzoisothiazole compounds and methods of treating schizophrenia US Patent  US9550741 Publication Date 1/24/2017 
Target
Name:
Vitamin D3 receptor
Synonyms:
1,25-dihydroxyvitamin D3 receptor | NR1I1 | Nuclear receptor subfamily 1 group I member 1 | Retinoic acid receptor RXR-alpha/Vitamin D3 receptor | VDR | VDR_HUMAN
Type:
Protein
Mol. Mass.:
48288.72
Organism:
Homo sapiens (Human)
Description:
P11473
Residue:
427
Sequence:
MEAMAASTSLPDPGDFDRNVPRICGVCGDRATGFHFNAMTCEGCKGFFRRSMKRKALFTCPFNGDCRITKDNRRHCQACRLKRCVDIGMMKEFILTDEEVQRKREMILKRKEEEALKDSLRPKLSEEQQRIIAILLDAHHKTYDPTYSDFCQFRPPVRVNDGGGSHPSRPNSRHTPSFSGDSSSSCSDHCITSSDMMDSSSFSNLDLSEEDSDDPSVTLELSQLSMLPHLADLVSYSIQKVIGFAKMIPGFRDLTSEDQIVLLKSSAIEVIMLRSNESFTMDDMSWTCGNQDYKYRVSDVTKAGHSLELIEPLIKFQVGLKKLNLHEEEHVLLMAICIVSPDRPGVQDAALIEAIQDRLSNTLQTYIRCRHPPPGSHLLYAKMIQKLADLRSLNEEHSKQYRCLSFQPECSMKLTPLVLEVFGNEIS
  
Inhibitor
Name:
BDBM50207144
Synonyms:
CHEMBL3940712 | US9550741, IV-11
Type:
Small organic molecule
Emp. Form.:
C27H35N5OS
Mol. Mass.:
477.665
SMILES:
O=C(NCc1ccccc1)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nsc3ccccc23)CC1 |r,wU:11.11,wD:14.15,(26.22,-29.78,;25.55,-28.45,;24.01,-28.34,;23.14,-29.63,;21.6,-29.58,;20.94,-28.19,;19.4,-28.09,;18.58,-29.42,;19.25,-30.75,;20.78,-30.86,;26.32,-27.12,;27.86,-27.12,;28.63,-25.78,;30.16,-25.78,;30.93,-27.12,;32.47,-27.12,;33.24,-25.78,;34.77,-25.78,;35.54,-27.12,;37.08,-27.12,;37.85,-25.78,;37.08,-24.45,;35.54,-24.45,;39.39,-25.78,;40.26,-27.02,;41.68,-26.55,;41.68,-25.01,;42.81,-23.99,;42.5,-22.45,;41.01,-21.99,;39.95,-23.02,;40.26,-24.5,;30.16,-28.45,;28.63,-28.45,)|
Structure:
Search PDB for entries with ligand similarity: